vimarsana.com

Page 2 - வியட்நாம் இராணுவம் மருத்துவ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vietnam Starts Human Trial of Coronavirus Vaccine

Thursday, 17 December, 2020 - 10:30 Vietnamese military medical officials administer a shot of the Covid-19 vaccine Nanocovax to a volunteer in Hanoi | AFP Asharq Al-Awsat A Vietnamese pharmaceutical company began testing a coronavirus vaccine on volunteers in Hanoi on Thursday, as developing countries jostle with richer nations to access affordable inoculations. Nanogen s Nanocovax is one of four under development in Vietnam, and a company representative said it is expected to cost around $5 a dose. Three volunteers received the jab on Thursday and will be monitored for 72 hours at the Vietnam Military Medical University. Nguyen Ngo Quang from the health ministry said 60 participants will receive the vaccine in the first phase of the trial.

What we know about Vietnam s homegrown COVID-19 vaccine, so far | Tuoi Tre News

Wednesday, December 16, 2020, 14:31 GMT+7 A researcher at Nanogen Pharmaceutical Biotechnology implementing tests on Nanocovax, Vietnam s first homegrown COVID-19 vaccine to be approved for human trial. Photo: Duyen Phan / Tuoi Tre Nanocovax – one of Vietnam’s domestically developed vaccines for COVID-19 – has officially received volunteers for its human clinical trial phase. Meanwhile, three other candidates are each running their own race to come up with an approved COVID-19 vaccine for mass inoculation. Developed by Vietnamese manufacturer Nanogen Pharmaceutical Biotechnology, Nanocovax will be brought to human trials under the supervision of the Vietnam Military Medical University. The vaccine roadmap Just one year ago on December 3, the first case of novel coronavirus infection was detected in China. Named COVID-19, the disease stemming from the SARS-CoV-2 pathogen managed to spread across the world, causing the most contagious and precarious epidemic in the last 100

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.